Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RARE earnings report is expected in 65 days (30 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RARE Earnings Reports FAQ
What is the earnings per share (EPS) for RARE?
The current EPS is -8.23.
What is the company's earnings growth rate?
Ultragenyx Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-30, based on the RARE's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ultragenyx Pharmaceutical Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RARE at this time, as Ultragenyx Pharmaceutical Inc has no recent EPS data to calculate it.
